This session program will review some of the more recent cases interpreting and applying the standards provided by the U.S. Supreme Court in its landmark decisions Mayo Collaborative Servs. v. Prometheus Labs., Inc.; Ass’n for Molecular Pathology v. Myriad Genetics, Inc.; and Alice Corp. v. CLS Bank Int’l as they apply to medical diagnostics technology and other chemical technologies dealing with products of nature and genetic code. In practice how is the two-part patent eligibility test being applied and what can we learn from these cases to develop and claim patentable inventions in this technical art?

How to patent medical diagnostics and genetics related inventions: What have recent cases taught us?

255th National Meeting (2018)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.